Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/1995
08/10/1995WO1995020942A1 Lure for facilitating the administration of drugs to certain animals, particularly dogs
08/10/1995DE4409569C1 New poly:glycerol poly:ricinoleate ester(s)
08/10/1995DE4404086A1 Solid pharmaceutical or cosmetic compsn. e.g. stick
08/10/1995DE4404011A1 Adhesive compsn. for moist surfaces, e.g. as pharmaceutical carrier
08/10/1995DE4403709A1 Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid A pharmaceutical composition for systemic transdermal administration containing the active substance of morphine-6-glucuronide
08/10/1995DE4403487A1 Transdermal therapeutic system for admin. of, e.g. Ketoprofen or oestradiol
08/10/1995CA2182593A1 Oral liquid compositions containing paroxetine resinate
08/10/1995CA2182485A1 Pharmaceutically active compounds and liposomes, and methods of use thereof
08/10/1995CA2182211A1 Compositions and devices for controlled release of active ingredients
08/10/1995CA2182038A1 Therapeutic agents containing thyroid hormones
08/10/1995CA2182037A1 Liquid pharmaceutical compositions comprising thyroid hormones
08/10/1995CA2159706A1 Method for preventing keratocyte loss
08/09/1995EP0666454A1 An air conditioning/providing system directly through natural heat preserving main body
08/09/1995EP0666078A2 Nasal spray compositions
08/09/1995EP0666076A2 Water in oil emulsion containing retinol
08/09/1995EP0665830A1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it.
08/09/1995EP0665759A1 Dry powder inhaler
08/09/1995EP0665756A1 Process and device for producing liquid, dispersed systems
08/09/1995EP0665755A1 Preparation of pharmaceutical compositions containing a calcitonin
08/09/1995EP0665746A1 CONTROLLED-pH FORMULATION FOR INTRAVESICULAR INSTILLATION OF TGF$g(a)PE 40?ab
08/09/1995EP0665745A1 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same
08/09/1995EP0665744A1 Stable extended release oral dosage composition
08/09/1995EP0665743A1 Interdigitation-fusion liposomes and gels
08/09/1995EP0665742A1 Blended lipid vesicles
08/09/1995EP0665741A1 Topical ophthalmic pharmaceutical vehicles
08/09/1995EP0665733A1 Vaginal sponge delivery system
08/09/1995EP0656883A4 Cationic lipids.
08/09/1995EP0593746A4 Transdermal drug delivery system.
08/09/1995EP0506900B1 Process for producing spagyric essences from plants
08/09/1995EP0463152B1 Method of inhibiting angiogenesis of tumors
08/09/1995CN1106608A Controlled release preparation containing a salt of morphine
08/09/1995CN1106294A Medicine compn. for bone-knitting and its prepn.
08/09/1995CN1106287A Blood nourishing granules
08/09/1995CN1106286A Fat-reducing granules
08/09/1995CN1106283A Toothache cigarette
08/09/1995CN1106272A Chinese medicine for prevention and treatment of tetanus
08/09/1995CN1106270A Chinese medicine fragrant inhalation and its prepn.
08/09/1995CN1106267A Chinese medicine for giving up drugs
08/09/1995CN1106259A Antiphlogistic and analgesic gel agent for external use containing propanoic acid non steroid pharmaceutical as effective composition
08/09/1995CN1106258A Zinc glycyrrhizate granules
08/09/1995CN1106257A Medicinal bag for preventing cough and asthma and its prodn. method
08/09/1995CN1106256A Health medicinal bag for stopping numbness and pain and its prodn. method
08/09/1995CN1029456C Method for prepn. of vagina lubricating agent in use for valva
08/08/1995US5439967 Propylene glycol stearate vesicles
08/08/1995US5439966 Polyethylene oxide temperature - or fluid-sensitive shape memory device
08/08/1995US5439954 Cosmetics for topical application to skin as sunscreen agents
08/08/1995US5439944 Red blood cell substitute emulsions containing alkyl- or alkylglyucerophosphoryl choline surfactants and methods of use
08/08/1995US5439882 Blood substitute
08/08/1995US5439690 Non-hazardous pest control
08/08/1995US5439689 Diltiazem formulation
08/08/1995US5439688 Process for preparing a pharmaceutical composition
08/08/1995US5439687 Dosage forms having zero-order dihydropyridine calcium antagonist release
08/08/1995US5439686 Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
08/08/1995US5439685 Vaginal tampon containing cholic acid or salt as microbiocide, dimethylsiloxane as protective film forming agent, hydroxy-propylmethyl cellulose as thickener, benzalkonium chloride and nonoxynol 9 as spermicidal agents
08/08/1995US5439672 Cosmetic composition based on an aqueous dispersion of small lipid spheres
08/08/1995US5439670 Self-propelling bronchodilator agents substantially free of chlorofluorocarbons
08/08/1995US5439669 Biological imaging emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
08/08/1995US5438988 Pressure-sensitive poly(N-vinyl lactam) adhesive composition and biomedical electrodes using same
08/08/1995CA1336579C Delivery systems for the controlled administration of lhrh analogs
08/04/1995CA2141645A1 Nasal spray compositions
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020641A1 Self-foaming multifunctional cleansing composition with hydrophobic carrier
08/03/1995WO1995020634A1 Use of bicontinuous microemulsions as pressure sensitive adhesives
08/03/1995WO1995020567A1 Codrugs as a method of controlled drug delivery
08/03/1995WO1995020542A1 Method of treatment of talc
08/03/1995WO1995020432A1 An apparatus for coating solid particles
08/03/1995WO1995020403A1 Aqueous topical compositions
08/03/1995WO1995020399A1 Pharmaceutical compositions comprising hirudin
08/03/1995WO1995020394A1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same
08/03/1995WO1995020393A1 Use of mometasone furoate for treating airway passage and lung diseases
08/03/1995WO1995020392A1 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14α,17α-ETHANOESTRA-1,3,5(10)-TRIENE-3,17β-DIOL
08/03/1995WO1995020384A1 Pharmaceutical compositions containing hiv protease inhibitors
08/03/1995WO1995020383A1 Modified-release metronidazole compositions and methods for making and using same
08/03/1995WO1995020382A1 Process for producing s(+)-ibuprofen particles
08/03/1995WO1995020381A1 Coating of biomedical objects with microspheres obtained with biocompatible polymers
08/03/1995WO1995020380A1 Intraorally soluble compressed molding and process for producing the same
08/03/1995WO1995020379A1 Liposomes containing encapsulated proteins, method of preparing them and pharmaceutical and cosmetic preparations containing such liposomes
08/03/1995WO1995020378A1 Compositions for treatment of glaucoma comprising pilocarpine and a beta-blocker
08/03/1995WO1995020377A1 Rapidly dissolving oral dosage form
08/03/1995WO1995012660A3 Recombinant p53 adenovirus methods and compositions
08/03/1995DE4402379A1 Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung Oral dosage form having acidic active ingredients, and processes for their preparation
08/03/1995DE19502566A1 N-Acetyl-Cystein-haltige pharmazeutische Zusammensetzungen N-acetyl-cysteine-containing pharmaceutical compositions
08/03/1995CA2182188A1 Agent, intended for transdermal administration, containing 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol
08/03/1995CA2181907A1 Pharmaceutical compositions comprising hirudin
08/02/1995EP0665019A1 Stable dry powders containing hirudin
08/02/1995EP0665010A1 Method of manufacturing wax matrices
08/02/1995EP0665009A1 Crystalline condition dislocating method
08/02/1995EP0665003A1 The use of a spin acceptor in a cosmetic on dermatological composition
08/02/1995EP0665001A1 Topical slimming composition containing two types of liposomes and its use
08/02/1995EP0665000A1 Skinmoisturizing composition for simultaneous treatment of upper and inner skin layers, and its use
08/02/1995EP0664724A1 Process for extracting and rebuffering and/or concentrating dissolved macromolecules of a macromolecular mixture.
08/02/1995EP0664705A1 Use of ergoline derivatives for the treatment of glaucoma
08/02/1995EP0664699A1 Hydrogel-based microsphere drug delivery systems
08/02/1995EP0664698A1 Method for forming controlled release polymeric substrate
08/02/1995EP0664697A1 Ranitidine chewable tablets
08/02/1995EP0664696A1 Sustained release compositions for treating periodontal disease.
08/02/1995EP0664695A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
08/02/1995EP0551292B1 Lateral edge coated controlled release pharmaceutical compositions
08/02/1995EP0550615B1 Drug delivery vehicles suspended in nonaqueous perfluorinated carrier
08/02/1995EP0525163B1 Binding of growth hormone to liposomes